3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
24
Prostatic Neoplasms, Castration-Resistant
4
Prostatic Diseases
3
Neoplasm Metastasis
3
Metastatic Castration-resistant Prostate Cancer
3
Urogenital Neoplasms
2
Triple Negative Breast Neoplasms
2
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
2
Male Urogenital Diseases
2
Genital Diseases, Male
2
Adenocarcinoma
2
Urogenital Diseases
1
Sleep Initiation and Maintenance Disorders
1
Prostate Cancer Metastatic
1
Non-metastatic Castration-resistant Prostate Cancer
1
Neoplasms by Site
1
Neoplasms
1
Metastatic Castration-resistant Prostate Neoplasms
1
Metastatic Castration-resistant Prostate Cancer (mCRPC)
1
High-Risk Localized Prostate Cancer
1
Fatigue
1
Depression
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Bulbo-Spinal Atrophy, X-Linked
1
Advanced Solid Tumor
1
Interventions
Therapeutics
4
Psilocybin
3
Surveys and Questionnaires
2
Oxygen
2
Methods
2
Cognitive Behavioral Therapy
2
enzalutamide
1
darolutamide
1
apalutamide
1
abacavir
1
Transurethral Resection of Prostate
1
Transcranial Magnetic Stimulation
1
Transcranial Direct Current Stimulation
1
Thyroidectomy
1
Standard of Care
1
Saline Solution
1
Psychotherapy
1
Physical Examination
1
Palliative Care
1
Niacin
1
Models, Nursing
1
Mindfulness
1
Methylphenidate
1
Melatonin
1
Injections
1
Infliximab
1
Hypnosis
1
Ethanol
1
Esketamine
1
Early Detection of Cancer
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Depression
×
darolutamide
×
Clear all
NCT07181122
2026-04-28
PRO-MIND
Ankara Etlik City Hospital
Recruiting
102 enrolled